STRS Ohio’s Arcadia Biosciences RKDA Stock Holding History

STRS Ohio’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3	Closed	-$12.5K	–	1934
2015 Q2	$16K	Buy	+3	New	+$18.7K	﹤0.01%	1828

Other funds holding RKDA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's RKDA Position: Q3 2015 in Review

STRS Ohio sold out of Arcadia Biosciences (RKDA) in Q3 2015, closing a stake of 3 shares — an estimated $12.5K sold.

STRS Ohio first reported a position in RKDA in Q2 2015 and held it in 1 quarter. The position peaked at $16K in Q2 2015. 28 funds tracked by Wall St. Rank hold RKDA as of Q3 2015.

STRS Ohio reported no remaining Arcadia Biosciences position as of Q3 2015 after selling out during the quarter.
STRS Ohio sold 3 Arcadia Biosciences shares in Q3 2015, an estimated $12.5K.
STRS Ohio first reported a position in Arcadia Biosciences in Q2 2015 and held it in 1 quarter.
STRS Ohio's Arcadia Biosciences position peaked at $16K in Q2 2015.
28 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2015.

Based on STRS Ohio's 13F filing for Q3 2015, filed 21 Oct 2015.